Guardant Health, Inc. (NASDAQ:GH) Receives Average Rating of “Buy” from Brokerages
Guardant Health, Inc. (NASDAQ:GH – Get Free Report) has been assigned an average rating of “Buy” from the twenty analysts that are currently covering the stock, MarketBeat reports. Twenty analysts have rated the stock with a buy recommendation. The average twelve-month price objective among analysts that have updated their coverage on the stock in the […]
Guardant Health, Inc. (NASDAQ:GH – Get Free Report) has been assigned an average rating of “Buy” from the twenty analysts that are currently covering the stock, MarketBeat reports. Twenty analysts have rated the stock with a buy recommendation. The average twelve-month price objective among analysts that have updated their coverage on the stock in the […]
